Cancer Research
Investment in cancer treatment technology, benefiting from breakthroughs and commercialization in cancer drugs, immunotherapy, and gene therapy.24H Performance
3.33%
Beta0.49
Post-market | Last updated at Jun 26, 2026 17:16:45Post-market | Last updated at Jun 26, 2026 17:16:45